Jaime W. Vieser - 29 Nov 2022 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Director
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Issuer symbol
TCRT
Transactions as of
29 Nov 2022
Net transactions value
+$812,500
Form type
4
Filing time
01 Dec 2022, 15:05:15 UTC
Previous filing
24 Jun 2022
Next filing
08 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Purchase $812,500 +1,250,000 $0.6500 1,250,000 29 Nov 2022 By Brushwood LLC F1, F2
holding TCRT Common Stock 745,321 29 Nov 2022 Direct
holding TCRT Common Stock 100,000 29 Nov 2022 By UTMA for child
holding TCRT Common Stock 75,000 29 Nov 2022 By UTMA for child
holding TCRT Common Stock 75,000 29 Nov 2022 By UTMA for child
holding TCRT Common Stock 75,000 29 Nov 2022 By UTMA for child
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are directly held by Brushwood LLC. The Reporting Person is the Manager of Brushwood LLC.
F2 The shares were purchased in a registered underwritten offering on November 29, 2022.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney